Lu He
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 5%
- Graphene and Nanomaterials Applications
- Nanoplatforms for cancer theranostics
Papers in
-
- Lymphoma Diagnosis and Treatment 4
-
- Neurofibromatosis and Schwannoma Cases 1
- Co-authors
- Weibo Cai (2 shared papers)Xiaoming Sun (1 shared paper)Hongjie Dai (1 shared paper)Xiangshan Fan (4 shared papers)Tao Yang (1 shared paper)Hongman Zhang (1 shared paper)Min Shi (1 shared paper)Min Xie (1 shared paper)
- Journals
- Cancer Medicine (2 papers)Frontiers in Pharmacology (1 paper)Histopathology (1 paper)Molecular Neurobiology (1 paper)Nature Nanotechnology (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Lu He
16 papers receiving 1.3k citations
Lu He's Hit Papers
Peers
Comparison fields: 5 of 93
- Biomaterials 400
- Biomedical Engineering 837
- Materials Chemistry 672
- Developmental Neuroscience 32
- Electronic, Optical and Magnetic Materials 90
Countries citing papers authored by Lu He
This map shows the geographic impact of Lu He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu He more than expected).
Fields of papers citing papers by Lu He
This network shows the impact of papers produced by Lu He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu He. The network helps show where Lu He may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice Hit paper breakdown → | 2006 | 1252 |
| 2 | 2016 | 18 | |
| 3 | 2022 | 10 | |
| 4 | 2016 | 6 | |
| 5 | 2021 | 6 | |
| 6 | 2023 | 5 | |
| 7 | Epstein-Barr virus-positive plasmacytoma in immunocompetent patients: a diagnostic dilemma. | 2020 | 5 |
| 8 | 2021 | 4 | |
| 9 | 2025 | 3 | |
| 10 | 2023 | 3 | |
| 11 | 2024 | 2 | |
| 12 | 2021 | 2 | |
| 13 | 2025 | 1 | |
| 14 | 2022 | 1 | |
| 15 | 2024 | 1 | |
| 16 | 2007 | 1 | |
| 17 | 2024 | 0 | |
| 18 | 2025 | 0 | |
| 19 | 2022 | 0 | |
| 20 | 2025 | 0 |
About Lu He
Lu He is a scholar working on Pathology and Forensic Medicine, Neurology, Oncology, Surgery and Genetics, having authored 21 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (2 papers), Cell Adhesion Molecules Research (2 papers), Sarcoma Diagnosis and Treatment (1 paper), Fatty Acid Research and Health (1 paper), Neurofibromatosis and Schwannoma Cases (1 paper), Nanoparticle-Based Drug Delivery (1 paper) and Cardiac tumors and thrombi (1 paper). The work is most often cited by research in Biomaterials (400 citations), Biomedical Engineering (837 citations), Materials Chemistry (672 citations), Developmental Neuroscience (32 citations) and Electronic, Optical and Magnetic Materials (90 citations). Lu He has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Weibo Cai, Xiaoming Sun, Hongjie Dai, Xiangshan Fan, Tao Yang, Hongman Zhang, Min Shi, Min Xie, Yuemei Xu and Jiong Shi. Their work appears in journals such as Cancer Medicine, Frontiers in Pharmacology, Histopathology, Molecular Neurobiology and Nature Nanotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.